Alterations in redox homeostasis and prostaglandins impair endothelial-dependent vasodilation in euglycemic autoimmune nonobese diabetic mice

Free Radic Biol Med. 2005 Oct 15;39(8):1089-98. doi: 10.1016/j.freeradbiomed.2005.05.027.

Abstract

We report herein the novel observation that alterations in oxidant/antioxidant balance are evident and cause vascular dysfunction in aortae of prediabetic nonobese-diabetic mice (NOD). We found that nitrotyrosine, a biochemical marker of oxidant stress, was higher in the NOD aortae when compared to age-matched non-autoimmune BALB/c controls or the diabetes-resistant NOD congenic strain, NOD.Lc7. The oxidant stress was localized to the intimal and medial layers, and endothelium-dependent relaxation to acetylcholine was decreased in isolated aortic rings from NOD mice. Inhibition of nitric oxide synthesis caused an endothelium-dependent contraction, and treatment with either a selective thromboxane A2/prostaglandin H2 receptor antagonist or a non-isozyme-specific cyclooxygenase inhibitor reversed this effect. Aortic rings from NOD.Lc7 did not display the paradoxical vasoconstriction. Furthermore, the vascular dysfunction was caused by oxidative stress, as treatment with a superoxide dismutase mimetic in vivo or with native antioxidant enzymes ex vivo inhibited the tissue oxidant stress and restored endothelium-dependent relaxation. Endothelial function was also restored by the inhibitors of NAD(P)H oxidase, diphenylene iodonium or apocynin. Our studies indicate that an oxidant stress that occurs prior to the onset of diabetes in this mouse model contributes to endothelial dysfunction independently of overt diabetes.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Acetophenones / pharmacology
  • Acetylcholine / pharmacology
  • Animals
  • Aorta / chemistry
  • Aorta / drug effects
  • Aorta / physiopathology
  • Cyclooxygenase Inhibitors / pharmacology
  • Diabetes Mellitus, Type 1 / metabolism
  • Diabetes Mellitus, Type 1 / physiopathology*
  • Endothelium, Vascular / chemistry
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / physiopathology*
  • Homeostasis
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred NOD
  • NADPH Oxidases / antagonists & inhibitors
  • NADPH Oxidases / metabolism
  • Nitric Oxide / metabolism
  • Onium Compounds / pharmacology
  • Oxidation-Reduction
  • Oxidative Stress*
  • Prediabetic State / metabolism
  • Prediabetic State / physiopathology*
  • Prostaglandin-Endoperoxide Synthases / metabolism
  • Prostaglandins / metabolism*
  • Receptors, Thromboxane A2, Prostaglandin H2 / antagonists & inhibitors
  • Receptors, Thromboxane A2, Prostaglandin H2 / metabolism
  • Tyrosine / analogs & derivatives
  • Tyrosine / analysis
  • Tyrosine / metabolism
  • Vasodilation*

Substances

  • Acetophenones
  • Cyclooxygenase Inhibitors
  • Onium Compounds
  • Prostaglandins
  • Receptors, Thromboxane A2, Prostaglandin H2
  • Nitric Oxide
  • 3-nitrotyrosine
  • Tyrosine
  • diphenyleneiodonium
  • acetovanillone
  • Prostaglandin-Endoperoxide Synthases
  • NADPH Oxidases
  • Acetylcholine